Methyldopa is an antihypertensive drug that is used to treat high blood pressure. However, during the manufacturing process, impurities may be formed as by-products that can affect the purity and quality of the drug. These impurities can be harmful to the patient and can cause adverse reactions. Therefore, it is essential to monitor and control the level of Methyldopa impurities to ensure the safety and efficacy of the drug.